Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

AdvaMed Privacy Comments Will Seek Clarity On PHI Disclosure Procedure

This article was originally published in The Gray Sheet

Executive Summary

HHS should clarify whether or not protected health information can be released to foreign governments without the permission of FDA under HIPAA privacy guidelines, AdvaMed says

You may also be interested in...



HHS Reaffirms “Business Associate” Category In HIPAA Final Rule

HHS dismisses suggestions to form a limited subsection of the "business associate" category for certain entities in the agency's final rule implementing the Health Insurance Portability & Accountability Act

Surging China Coronavirus Trials Prompt Tougher Criteria

A surge in Chinese applications for clinical trials for coronavirus treatments, and a fall in patient numbers, are complicating recruitment efforts for the most promising drugs, prompting official moves to tighten study rules. 

UsernamePublicRestriction

Register

MT016396

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel